ArticleChemistry (Weinheim an der Bergstrasse, Germany)2026
Cyclodextrin-Enhanced Photocatalytic Hydrogen Evolution Based on Formate Decomposition With Bio/Metal Catalysts.
Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cyclodextrin-Enhanced Photocatalytic Hydrogen Evolution Based on Formate Decomposition With Bio/Metal Catalysts.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Formic acid is an attractive hydrogen carrier in terms of hydrogen capacity and safety. Focusing on hydrogen release from formic acid, the developments of catalysts with easy controllability in mild conditions have been desirable. Previous study reported a hybrid catalytic system of enzymes, photosensitizers, and metal nanoparticles for controllable hydrogen production with visible light. However, methyl viologen, which is a toxic compound, was utilized as an electron mediator from photosensitizers to metal nanoparticles. 9-Mesityl-10-methyl acridinium (Mes-Acr
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.